<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | English Acosta | Activity</title>
	<link>https://www.catswannabecats.com/members/flavorwindow8/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/flavorwindow8/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for English Acosta.</description>
	<lastBuildDate>Sun, 28 Jun 2026 07:29:42 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">9f3d8d226db7e46e9b6e46ff0efc23ab</guid>
				<title>English Acosta posted an update: This literature review aims to provide a comprehensive [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24039/</link>
				<pubDate>Sun, 08 Jun 2025 11:15:13 -0400</pubDate>

									<content:encoded><![CDATA[<p>This literature review aims to provide a comprehensive current summary of the pathogenesis, clinical features, disease course, host immune responses, and current investigational antiviral and immunomodulatory pharmacotherapies to facilitate the development of future therapies and measures for prevention and control.The material properties of the&hellip;<span class="activity-read-more" id="activity-read-more-24039"><a href="https://www.catswannabecats.com/activity/p/24039/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">29377044c12a629f24ccdffe646aac25</guid>
				<title>English Acosta posted an update: Stroke is a leading cause of death and disability worldwide. [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19712/</link>
				<pubDate>Thu, 05 Jun 2025 09:15:28 -0400</pubDate>

									<content:encoded><![CDATA[<p>Stroke is a leading cause of death and disability worldwide. The reasons for increased stroke burden in developing countries are inadequately controlled risk factors resulting from poor public awareness and inadequate infrastructure. Computed tomography and MRI are common neuroimaging modalities used to assess stroke with diffusion-weighted MRI,&hellip;<span class="activity-read-more" id="activity-read-more-19712"><a href="https://www.catswannabecats.com/activity/p/19712/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4d6dd3b14acbe4c442b40e61cb0f860a</guid>
				<title>English Acosta posted an update: Despite the recent proliferation of mental health apps, few [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/9829/</link>
				<pubDate>Sat, 31 May 2025 23:10:42 -0400</pubDate>

									<content:encoded><![CDATA[<p>Despite the recent proliferation of mental health apps, few have directly focused on the prevention of self-harm. The available apps are described and the limited, although encouraging, outcome data are summarised. The design, content and initial outcome of the only app developed specifically for adolescents, BlueIce, is presented.Background A&hellip;<span class="activity-read-more" id="activity-read-more-9829"><a href="https://www.catswannabecats.com/activity/p/9829/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">64109710616c81b56b88f44f06edd602</guid>
				<title>English Acosta became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/9675/</link>
				<pubDate>Sat, 31 May 2025 23:00:15 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>